Jindriska R. Lindsay
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Bortezomib in Patients Who Fail BTKi in Waldenström Macroglobulinaemia.
Journal: Hematology reports
Published: February 15, 2026
Evaluating the Real-World Value of Daratumumab Addition to Multiple Myeloma Induction Therapy by Real-World Minimal Residual Disease Assessment and Extended Genetic Profiling.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 07, 2025
Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathy.
Journal: Seminars in hematology
Published: April 19, 2025
Bing-Neel syndrome: a case series of 46 patients from the United Kingdom.
Journal: Blood advances
Published: March 07, 2025
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma.
Journal: The New England journal of medicine
Published: December 09, 2024
Pomalidomide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Survival and Subgroup Analyses From the OPTIMISMM Trial.
Journal: European journal of haematology
Published: July 30, 2024
Ethnic diversity in presentation and outcome of Waldenström macroglobulinemia and IgM monoclonal gammopathy of clinical significance in the United Kingdom.
Journal: Haematologica
Published: March 13, 2024
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial.
Journal: British journal of haematology
Published: September 25, 2022
Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial.
Journal: Blood cancer journal
Published: July 28, 2022
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.
Journal: European journal of haematology
Published: June 08, 2021
Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance.
Journal: Calcified tissue international
Published: March 03, 2021
Last Updated: 09/26/2026